Palantir Technologies Inc
Palantir stock plummets 20% from highs in longest losing streak since April 2024
Palantir shares sank into bear market territory Wednesday after six straight days of heavy selling. The slide marks the longest such streak for the artificial intelligence software company since April 2024, and brings shares down 20% from the recent record. Shares closed in correction territory on Tuesday after accumulating a 15% loss from the highs. […]
Read More
CNBC Daily Open: Trump’s expanded tariffs mean putting out home fires could be more expensive
Cargo containers stacked aboard a ship at the Jakarta International Container Terminal in Tanjung Priok Port on Aug. 7, 2025. Str | Afp | Getty Images Tariff-related ruction appears to be settling down, but U.S. President Donald Trump is still reshaping global trade and industry — and everyday life. After the Trump administration hinted it could […]
Read More
CNBC Daily Open: Not even fire extinguishers can escape the Trump administration’s tariffs
An aerial view of a cargo ship being loaded with shipping containers at the Port of Baltimore in Baltimore, Maryland, on August 7, 2025. Jim Watson | Afp | Getty Images Even as tariff-related ruction appears to be settling down for the summer, U.S. President Donald Trump’s administration is still reshaping global trade and industry. […]
Read More
Palantir stock slumps 9%, falling for a fifth straight day from record
CEO of Palantir Technologies Alex Karp attends the Pennsylvania Energy and Innovation Summit on the campus of Carnegie Mellon University in Pittsburgh, Pennsylvania on July 15, 2025. Andrew Caballero-reynolds | Afp | Getty Images Palantir‘s stock slumped more than 9% on Tuesday, falling for a fifth straight day to continue its pullback from all-time highs. […]
Read More
Stocks making the biggest moves midday: Home Depot, Intel, Viking Therapeutics, Nvidia and more
These are some of the stocks making the biggest moves during midday trading: Viking Therapeutics — Shares tumbled 42% after phase 2 trial results showed Viking’s experimental oral obesity drug had more side effects than expected. About 20% of the patients in the trial quit using the drug due to symptoms such as nausea and […]
Read More
GPT-5’s rollout fell flat for consumers, but the AI model is gaining where it matters most
Sam Altman turned OpenAI into a cultural phenomenon with ChatGPT. Now, three years later, he’s chasing where the real money is: Enterprise. Last week’s rollout of GPT-5, OpenAI’s newest artificial intelligence model, was rocky. Critics bashed its less-intuitive feel, ultimately leading the company to restore its legacy GPT-4 to paying chatbot customers. But GPT-5 isn’t […]
Read More
Palantir’s astronomical growth in 3 charts
Alexander Karp, chief executive officer and co-founder of Palantir Technologies Inc. Scott Eelis | Bloomberg | Getty Images Palantir‘s astronomical rise since its public debut on the New York Stock Exchange in a 2020 direct listing has been nothing short of a whirlwind. Over nearly five years, the Denver-based company, whose cofounders include renowned venture […]
Read More
The S&P 500 is on the cusp of another record. How long can this bull keep dodging danger?
A week removed from a brutal payroll report that triggered worry over a tapped consumer and a trapped Federal Reserve, the broad stock indexes are back at the cusp of all-time highs, market volatility has returned to year-to-date lows and some investors are calling off the August hurricane watch. The S & P 500’s 2.4% […]
Read More
Big Tech’s trillion-dollar market cap club could have a new member in the next few years, Dan Ives says
Palantir is on its way to becoming a trillion-dollar company, according to prominent tech bull Dan Ives. The AI company’s stock has surged more than 140% since the beginning of the year. Earnings beats , lucrative military contracts and the firm’s CEO boasting about “crazy, efficient revolution” in terms of growing revenue while downsizing headcount, […]
Read More
Stocks making the biggest moves midday: Pfizer, Palantir, Coinbase, Staar Surgical and more
Check out some of the companies making the biggest moves midday: Staar Surgical — The implantable eye lens maker ripped 45% higher after agreeing to be bought by Alcon for $28 per share in cash, valuing Staar at about $1.5 billion. The deal is expected to close in the next six to 12 months. DigitalOcean […]
Read More